Glenn Haifer 博士和 Ampersand Capital Partners 收购澳大利亚生物制品 CDMO Luina Bio，更名为 AcuraBio
Aug 31, 2022 12:00 HKT |  |
|
Glenn Haifer 博士和 Ampersand Capital Partners 收購澳大利亞生物製品 CDMO Luina Bio，更名為 AcuraBio
Aug 31, 2022 12:00 HKT | |
|
글렌 하이퍼 박사와 앰퍼샌드 캐피탈 파트너스, 호주의 바이오로직스 CDMO 루이나 바이오 인수 후 아쿠라바이오로 리브랜딩
Aug 31, 2022 12:00 HKT | |
|
아방스 클리니컬, 인포마파마인텔리전스 어워드 2022에서 올해의 바이오테크 기업상 후원
Aug 31, 2022 11:00 HKT |  |
|
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
Aug 30, 2022 21:00 HKT | |
|
Avance 临床赞助商在 2022 年 Informa Pharma Intelligence Awards 中获得年度生物技术公司奖
Aug 30, 2022 06:00 HKT | |
|
Avance 臨床贊助商在 2022 年 Informa Pharma Intelligence Awards 中獲得年度生物技術公司獎
Aug 30, 2022 06:00 HKT | |
|
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
Aug 29, 2022 18:00 HKT | |
|
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully
Aug 15, 2022 16:50 HKT |  |
|
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
Aug 09, 2022 20:30 HKT |  |
|
노보텍의 유연 근무 정책, 최고 유연 근무 프로그램의 ‘2022년 우수상’ 최종 후보로 선정
Jul 26, 2022 20:00 HKT |  |
|
冠科美博 (Apollomics Inc.) 扩充其领导团队，任命 Jane Wang 博士担任首席科学官一职
Jul 26, 2022 09:19 HKT |  |
|
冠科美博 (Apollomics Inc.) 擴充其領導團隊，任命 Jane Wang 博士擔任首席科學官一職
Jul 26, 2022 09:18 HKT | |
|
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
Jul 26, 2022 09:17 HKT | |
|
Novotech 的灵活工作政策入围最佳工作场所灵活性计划“2022 年卓越奖”
Jul 25, 2022 21:00 HKT | |
|
Novotech 的靈活工作政策入圍最佳工作場所靈活性計劃“2022 年卓越獎”
Jul 25, 2022 21:00 HKT | |
|
Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022"
Jul 25, 2022 09:00 HKT | |
|
TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally
Jul 20, 2022 09:00 HKT |  |
|
노보텍과 엔드포인트, “중국의 세포 및 유전자 치료의 진화: 범용성 CAR-T 사례”에 관해 발표
Jul 19, 2022 18:00 HKT | |
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years
Jul 19, 2022 11:00 HKT |  |
|